Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Diagnostic significance of CD20 and FMC7 expression in B-cell disorders.

Delgado J, Matutes E, Morilla AM, Morilla RM, Owusu-Ankomah KA, Rafiq-Mohammed F, del Giudice I, Catovsky D.

Am J Clin Pathol. 2003 Nov;120(5):754-9.

PMID:
14608903
2.

Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL).

Monaghan SA, Peterson LC, James C, Marszalek L, Khoong A, Bachta DJ, Karpus WJ, Goolsby CL.

Cytometry B Clin Cytom. 2003 Nov;56(1):30-42.

3.
4.
5.

FMC7 antigen expression on normal and malignant B-cells can be predicted by expression of CD20.

Hübl W, Iturraspe J, Braylan RC.

Cytometry. 1998 Apr 15;34(2):71-4.

PMID:
9579603
6.

Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b).

Moreau EJ, Matutes E, A'Hern RP, Morilla AM, Morilla RM, Owusu-Ankomah KA, Seon BK, Catovsky D.

Am J Clin Pathol. 1997 Oct;108(4):378-82.

PMID:
9322589
7.

[Density expression of the CD20 antigen on population of tumor cells in patients with chronic B-lymphocyte lymphoproliferative diseases].

Suková V, Klabusay M, Coupek P, Brychtová Y, Doubek M, Mayer J.

Cas Lek Cesk. 2006;145(9):712-6; discussion 716-7. Czech.

PMID:
17091727
8.

Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.

Nelson BP, Variakojis D, Peterson LC.

Mod Pathol. 2002 Nov;15(11):1111-20.

9.

CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia.

Huang JC, Finn WG, Goolsby CL, Variakojis D, Peterson LC.

Am J Clin Pathol. 1999 Jan;111(1):123-30.

PMID:
9894463
10.

Immunophenotyping of mature B-cell non Hodgkin lymphoma involving bone marrow and peripheral blood: critical analysis and insights gained at a tertiary care cancer hospital.

Gujral S, Polampalli SN, Badrinath Y, Kumar A, Subramanian PG, Nair R, Gupta S, Sengar M, Nair C.

Leuk Lymphoma. 2009 Aug;50(8):1290-300.

PMID:
19811331
11.

The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.

Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH, Catovsky D.

Leukemia. 1994 Oct;8(10):1640-5.

PMID:
7523797
13.

Unsupervised immunophenotypic profiling of chronic lymphocytic leukemia.

Habib LK, Finn WG.

Cytometry B Clin Cytom. 2006 May;70(3):124-35.

14.

Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.

Almasri NM, Duque RE, Iturraspe J, Everett E, Braylan RC.

Am J Hematol. 1992 Aug;40(4):259-63.

PMID:
1380203
15.

Utilization of a scoring system for diagnosis of chronic lymphocytic leukemia in Thai patients.

Promsuwicha O, Songmuang W, Auewarakul CU.

J Med Assoc Thai. 2011 Feb;94 Suppl 1:S232-8.

PMID:
21721452
16.

Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.

Gervasi F, Lo Verso R, Giambanco C, Cardinale G, Tomaselli C, Pagnucco G.

Ann N Y Acad Sci. 2004 Dec;1028:457-62.

PMID:
15650271
17.

Detection of subgroups of chronic B-cell leukemias by FMC7 monoclonal antibody.

Huh YO, Pugh WC, Kantarjian HM, Stass SA, Cork A, Trujillo JM, Keating MJ.

Am J Clin Pathol. 1994 Mar;101(3):283-9.

PMID:
8135183
18.

Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy.

Maeshima AM, Taniguchi H, Nomoto J, Maruyama D, Kim SW, Watanabe T, Kobayashi Y, Tobinai K, Matsuno Y.

Cancer Sci. 2009 Jan;100(1):54-61. doi: 10.1111/j.1349-7006.2008.01005.x. Epub 2008 Nov 25.

19.
20.

Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemia.

Tefferi A, Bartholmai BJ, Witzig TE, Li CY, Hanson CA, Phyliky RL.

Am J Clin Pathol. 1996 Oct;106(4):457-61.

PMID:
8853032

Supplemental Content

Support Center